{
    "organizations": [],
    "uuid": "27feed18bb0bf70c5dbfc812027461fe7023cd1a",
    "author": "",
    "url": "https://www.reuters.com/article/brief-stemline-therapeutics-q4-loss-per/brief-stemline-therapeutics-q4-loss-per-share-0-93-idUSASC09SMV",
    "ord_in_thread": 0,
    "title": "BRIEF-Stemline Therapeutics Q4 Loss Per Share $0.93",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 16, 2018 / 11:44 AM / Updated 13 minutes ago BRIEF-Stemline Therapeutics Q4 Loss Per Share $0.93 Reuters Staff March 16 (Reuters) - Stemline Therapeutics Inc: * STEMLINE THERAPEUTICS REPORTS FOURTH QUARTER 2017 FINANCIAL RESULTS * Q4 LOSS PER SHARE $0.93 * Q4 EARNINGS PER SHARE VIEW $-0.70 — THOMSON REUTERS I/B/E/S * ‍ENDED Q4 OF 2017 WITH $66.2 MILLION IN CASH, CASH EQUIVALENTS AND INVESTMENTS​ Source text for Eikon: Further company coverage:",
    "published": "2018-03-16T13:44:00.000+02:00",
    "crawled": "2018-03-16T14:01:05.030+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "updated",
        "minute",
        "ago",
        "therapeutic",
        "q4",
        "loss",
        "per",
        "share",
        "reuters",
        "staff",
        "march",
        "reuters",
        "stemline",
        "therapeutic",
        "inc",
        "stemline",
        "therapeutic",
        "report",
        "fourth",
        "quarter",
        "financial",
        "result",
        "q4",
        "loss",
        "per",
        "share",
        "q4",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "q4",
        "million",
        "cash",
        "cash",
        "equivalent",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}